186 related articles for article (PubMed ID: 1421636)
1. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
Wüthrich B; Kägi MK; Joller-Jemelka H
Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
[TBL] [Abstract][Full Text] [Related]
3. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.
Pucci N; Lombardi E; Novembre E; Farina S; Bernardini R; Rossi E; Favilli T; Vierucci A
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858
[TBL] [Abstract][Full Text] [Related]
4. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
[TBL] [Abstract][Full Text] [Related]
6. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous CD30+ cells in children with atopic dermatitis.
Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
Tsuda S; Kato K; Miyasato M; Sasai Y
J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood.
Halmerbauer G; Frischer T; Koller DY
Allergy; 1997 Jul; 52(7):765-9. PubMed ID: 9265994
[TBL] [Abstract][Full Text] [Related]
11. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
12. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis.
Wüthrich B; Joller-Jemelka H; Helfenstein U; Grob PJ
Dermatologica; 1990; 181(2):92-7. PubMed ID: 2242792
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
14. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis.
Furue M; Koga T; Yamashita N
Br J Dermatol; 1999 Jan; 140(1):67-72. PubMed ID: 10215770
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis.
Miyasato M; Tsuda S; Nakama T; Kato K; Kitamura N; Nagaji J; Sasai Y
J Dermatol; 1996 Jun; 23(6):382-8. PubMed ID: 8708149
[TBL] [Abstract][Full Text] [Related]
16. Measurement of inflammatory mediators of eosinophils and lymphocytes in blood in acute asthma: serum levels of ECP influence the bronchodilator response.
Di Lorenzo G; Pacor ML; Morici G; Drago A; Esposito-Pellitteri M; Candore G; Lo Bianco C; Caruso C
Int Arch Allergy Immunol; 2002 Apr; 127(4):308-15. PubMed ID: 12021550
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases.
Kim TY; Park HJ; Kim CW
J Dermatol Sci; 1997 Aug; 15(2):89-94. PubMed ID: 9279689
[TBL] [Abstract][Full Text] [Related]
18. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
19. Relationships between eosinophil-associated parameters and disease severity in atopic dermatitis.
Nakama T
Kurume Med J; 1995; 42(2):95-106. PubMed ID: 7564170
[TBL] [Abstract][Full Text] [Related]
20. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis.
Bruijnzeel PL; Kuijper PH; Kapp A; Warringa RA; Betz S; Bruijnzeel-Koomen CA
Clin Exp Allergy; 1993 Feb; 23(2):97-109. PubMed ID: 8448687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
